Results for: science
Nine years ago, a small group of visionaries managed to get 40 local startups together and they called it Slush – an event for startups by startups, and the rest is history. A couple of weeks ago, the world’s leading startup and technology conference was sold out, gathering up to 20 000 attendees from over… Read more »
Lengthy sentences, complicated words, weird abbreviations—scientific papers are not known for their reader-friendliness. When trying to tackle such a paper, you often blame yourself for having to read the same sentence twice, or more, to fully understand it. You may think it’s because of your own lack of knowledge or poor concentration. Next time, you… Read more »
“No one in their right mind would come to Helsinki in November”, stated this year’s catch line for the start-up event Slush – and yet they did. Last week, the sold-out conference gathered over 17,000 people from 124 countries under the same roof for two days. Slush started in 2008 as an insider meeting for… Read more »
Personalized medicine, customized treatment, precision medicine. Call it what you like, but the ability to tailor treatments and prevention strategies to the unique characteristics of each patient is inevitably changing the way cancer is treated. Precision medicine is arousing a growing interest both within the big pharma and the public sector. According to the Personalized… Read more »
Last week, the Finnish Government had big decisions ahead of them: they agreed on the General Government Fiscal Plan for 2017-2020, or the so-called ”Finland’s stability program.” The objective of the program is to revive the Finnish economy that has been struggling to get back on the track of growth and rising employment. While the… Read more »
A recent study published in The New England Journal of Medicine brought encouraging news for colon cancer patients: by using gene-expression analysis and bioinformatic tools, researchers had found a candidate biomarker that could potentially identify high-risk individuals who would benefit from adjuvant chemotherapy. This is where data from previous clinical trials came in handy: the biomarker was validated in… Read more »
A few years ago at the University of California in Berkeley, the biochemist Jennifer Doudna had a revolutionary dream: “Imagine if we could have a genome-editing technology like the find-and-replace function in a text editor.” Professor Doudna, now among Time magazine’s 100 most influential people in the world, shared her scientific journey in the CRISPR genome-editing… Read more »
It all started with a young researcher’s passion to understand and improve the health of newborns and their mothers. Dr. Paula Rantakallio (1930–2012), a pioneer and later a professor emerita in public health at the University of Oulu, was a driving force in the initiation of the Northern Finland Birth Cohort (NFBC) studies in the… Read more »
Medical Science Liaison (MSL), Medical Science Relations, Medical Manager, Scientific Advisor, Medical Advisor. There are many names for the field-based medical expert role, which has been established in recent years as the cornerstone of medical affairs within the pharmaceutical industry.
The bustle around real-world data (RWD) has been increasing in recent years. This is hardly surprising, since RWD can provide new insights on the benefit-risk ratio throughout a medicinal product’s life cycle, or update our current understanding of medical practices.